Study of Ixekizumab in Healthy Participants

Stopped At the protocol-specified interim analysis, the sponsor decided to stop the trial.

Conditions

• Healthy

Interventions

• BIOLOGICAL: Ixekizumab

Sponsor

Eli Lilly and Company